Cue Health (HLTH)
Empowering people to live their healthiest lives
Overview
IPO Stage
Robinhood
Not Provided
IPO
Nasdaq
$15 - $17
Equity - Common
Series C
S-1
$2.3B
Goldman Sachs, Morgan Stanley, Cowen
0
2010
Healthcare & Pharmaceuticals
HealthTech
B2B/B2C
Medium
High
Income Statement
|
Revenue |
$22,953,000 |
|
Operating Expenses |
|
|
Research/Technology & Development |
$28,478,000 |
|
Sales & Marketing |
$714,000 |
|
General & Administrative |
$23,936,000 |
|
Total Operating Expenses |
$68,079,000 |
|
Operating Income |
$0 |
|
Other Income, Net |
$47,000 |
|
Income (Loss) Before Provision For (Benefit From) Income Taxes |
$0 |
|
Provision For (Benefit From) Income Taxes |
$0 |
| Net Income (Loss) |
$-47,352,000 |
|
Net Income (Loss) Attributable to Common Stockholders: |
|
|
Basic |
$0.00 |
|
Diluted |
$0.00 |
|
Net Income (Loss) Per Share Attributable to Common Stockholders: |
|
|
Basic |
$-2.90 |
|
Diluted |
$-2.90 |
|
Weighted-Average Shares of Common Stock Used For Pro Forma: |
|
|
Basic |
0 |
|
Diluted |
0 |
Balance Sheet - Assets
|
Current Assets |
|
|
Cash and Cash Equivalents |
$121,578,000 |
|
Accounts Receivable |
$4,168,000 |
|
Total Current Assets |
$183,698,000 |
|
Property and Equipment, Net |
$103,683,000 |
|
Goodwill |
$0 |
|
Intangible Assets, Net |
$2,038,000 |
|
Restricted Cash |
$6,000,000 |
|
Other Assets |
$0 |
| Total Assets |
$316,328,000 |
Balance Sheet - Liabilities
|
Current Liabilities |
|
|
Accounts Payable |
$23,847,000 |
|
Accrued Expenses |
$0 |
|
Other Current Liabilities |
$0 |
|
Total Current Liabilities |
$155,896,000 |
| Total Liabilities |
$241,405,000 |
|
Commitments and Contingencies |
|
|
Convertible Preferred Stock |
$0 |
|
Stockholders' (deficit) Equity |
|
|
Common Stock |
$0 |
|
Additional Paid In Capital |
$9,036,000 |
|
Accumulated Other Comprehensive Income (Loss) |
$0 |
| Total Stockholders' (Deficit) Equity |
$-101,400,000 |
Statements of Cash Flows
|
Cash Flows from Operating Activites |
|
|
Net Cash Provided By (Used In) Operating Activities |
$92,655,000 |
|
Cash Flows from Investing Activites |
|
|
Net Cash Provided By (Used In) Investing Activities |
$-78,148,000 |
|
Cash Flows from Financing Activites |
|
|
Net Cash Provided By (Used In) Financing Activities |
$100,243,000 |
| Total Cash, Cash Equivalents, and Restricted Cash |
$0 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual